e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages
Kylie B.R. Belchamber, Richa Singh, Craig M. Batista, Moira K. Whyte, David H. Dockrell, Iain Kilty, Matthew J. Robinson, Jadwiga A. Wedzicha, Peter J. Barnes, Louise E. Donnelly
Source:
Eur Respir J, 54 (4) 1802244; 10.1183/13993003.02244-2018
Journal Issue:
October
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kylie B.R. Belchamber, Richa Singh, Craig M. Batista, Moira K. Whyte, David H. Dockrell, Iain Kilty, Matthew J. Robinson, Jadwiga A. Wedzicha, Peter J. Barnes, Louise E. Donnelly. Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages. Eur Respir J, 54 (4) 1802244; 10.1183/13993003.02244-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Related content which might interest you:
Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD
Source: Eur Respir J, 54 (4) 1901641; 10.1183/13993003.01641-2019
Year: 2019
Reduced phagocytosis of bacterial pathogens by macrophages from COPD patients
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Reduced phagocytosis of pathogenic bacteria by neutrophils from COPD patients
Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Year: 2012
Bacterial load and defective monocyte-derived macrophage bacterial phagocytosis in biomass smoke-related COPD
Source: Eur Respir J, 53 (2) 1702273; 10.1183/13993003.02273-2017
Year: 2019
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Decreased neutrophil phagocytosis and killing of bacteria in COVID-19 patients
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Decreased degranulating and mast cells in the small airway wall of COPD patients is indicative of dysfunctional immunity.
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages
Source: International Congress 2016 – Airway response to infection
Year: 2016
Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS
Source: Eur Respir J, 52 (2) 1702590; 10.1183/13993003.02590-2017
Year: 2018
Resident alveolar macrophages mediate early alveolar epithelial death signaling and dysfunction
Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Year: 2012
Impaired Alveolar Macrophage Efferocytosis in ARDS causes accumulation of apoptotic neutrophils & prolonged inflammation
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Alveolar macrophages are a more important source of active IL-18 compared to dendritic or monocyte cells in the presence of the bacterial virulence factor SipB
Source: Eur Respir J 2002; 20: Suppl. 38, 213s
Year: 2002
Mesenchymal stromal cells (MSC) anti-microbial effect in acute respiratory distress syndrome (ARDS) is mediated in part by enhanced alveolar macrophage phagocytosis through cell contact-dependent mitochondrial transfer leading to improved macrophage bioenergetics
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept